The UIC Pharmacogenomics Laboratory is dedicated to conducting research to determine how we can best utilize genetic information to personalize drug therapy. The primary research activities of the Pharmacogenomics Laboratory investigators involve neuropsychiatric and cardiovascular medications, with additional collaborations with oncology and internal medicine colleagues. We are conducting research to determine how best to use genetic markers associated with pathways of drug action as predictors of medication response and activity in the body. In doing so, we hope to ultimately translate our research activities into clinically useful tools to help us improve clinical outcomes from drug therapy and to facilitate the development of new medications for the future.
In the News
There are no news items to display.